vaccine

Germany's BioNTech, a Pfizer partner in Covid-19 vaccines, has announced that the two companies will begin testing next-generation vaccines in humans in the second half of the year that protect against a wide variety…
Read More...

Biotechnology company Moderna has announced positive preliminary results for a modified version of its Omicron variant vaccine. A booster dose of 50 micrograms resulted in "a greater response of antibodies…
Read More...

The World Health Organization (WHO) announced today that it has approved an emergency vaccine for Covid-19, Convidecia, of Chinese laboratories at CanSino Biologics as Beijing struggles to contain a pandemic flare-up.…
Read More...

The European Medicines Agency (EMA) announced today that it hopes to have vaccines adapted to treat coronavirus variants, such as Omicron, which will be approved by September. "Our priority is to ensure that…
Read More...

"I am a bitter defeat," German Health Minister Karl Lauterbach told the state-run Robert Koch Institute, led by Lothar Wheeler. Yesterday's failure in the German parliament to introduce compulsory…
Read More...

The prospect of introducing mandatory vaccination for citizens over the age of 18 against coronavirus seems to be abandoned, due to the lack of chances to be voted in favor by the Federal Parliament, according to…
Read More...

Sweden will give a fourth dose of the COVID-19 vaccine to those over 65 to boost their body's defenses against the disease, the country's health service announced today. "For people aged 65 and over, four months…
Read More...

The so-called booster dose of Covid-19 vaccine continues to provide strong protection to the elderly almost 4 months after the third dose, according to new data released today by the British health authorities.…
Read More...

Elderly and vulnerable groups can be vaccinated from today. Thoughts on extending the vaccination program with 4th dose for everyone from autumn. From today, Monday, in England, the distribution of the fourth dose…
Read More...

Production of the Russian Sputnik-V vaccine in Egypt will begin in six months, said the management of the pharmaceutical company Minapharm, which about a year ago signed an agreement with the Russian Direct Investment…
Read More...